Boston Partners - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
Boston Partners ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$3,049,684
+9.1%
29,940
+8.1%
0.00%0.0%
Q2 2023$2,794,201
+9.7%
27,6900.0%0.00%0.0%
Q1 2023$2,547,478
-6.7%
27,690
-8.0%
0.00%0.0%
Q4 2022$2,730,670
-98.0%
30,100
-98.3%
0.00%
-98.0%
Q3 2022$135,136,000
-65.1%
1,772,449
-61.3%
0.20%
-63.5%
Q2 2022$387,674,000
-4.3%
4,584,318
-0.6%
0.54%
+10.4%
Q1 2022$404,961,000
-1.0%
4,610,175
-1.4%
0.49%
-0.4%
Q4 2021$409,194,000
+14.1%
4,677,403
+6.7%
0.49%
+8.6%
Q3 2021$358,605,000
-37.6%
4,384,549
-30.4%
0.45%
-38.1%
Q2 2021$574,844,000
+14.7%
6,299,760
+7.5%
0.73%
+9.1%
Q1 2021$501,153,000
-12.3%
5,860,571
-3.1%
0.67%
-24.4%
Q4 2020$571,408,000
+4.7%
6,051,135
-3.6%
0.89%
-10.6%
Q3 2020$545,977,000
-6.0%
6,278,480
-5.6%
0.99%
-6.8%
Q2 2020$581,049,000
+114.1%
6,652,523
+102.0%
1.07%
+98.0%
Q1 2020$271,448,000
-17.3%
3,292,818
-5.0%
0.54%
+131.3%
Q4 2019$328,164,000
+98.0%
3,465,592
+81.7%
0.23%
+4.0%
Q3 2019$165,747,000
-53.7%
1,907,221
-51.4%
0.22%
-52.3%
Q2 2019$358,106,000
-42.4%
3,922,560
-39.3%
0.47%
-42.9%
Q1 2019$621,296,000
+2.7%
6,462,408
-8.3%
0.82%
-5.3%
Q4 2018$604,685,000
+25.6%
7,046,794
+26.1%
0.87%
+55.5%
Q3 2018$481,372,000
+13.7%
5,586,949
-0.4%
0.56%
+10.0%
Q2 2018$423,525,000
+92.5%
5,606,630
+106.0%
0.51%
+91.7%
Q1 2018$220,008,000
+42.2%
2,721,194
+47.6%
0.26%
+45.6%
Q4 2017$154,763,000
-2.9%
1,843,302
-0.8%
0.18%
-7.6%
Q3 2017$159,461,000
+18.2%
1,857,435
+14.9%
0.20%
+14.5%
Q2 2017$134,960,000
+13.1%
1,616,862
+0.7%
0.17%
+13.2%
Q1 2017$119,286,000
+5.1%
1,606,117
+3.1%
0.15%
+2.0%
Q4 2016$113,460,000
-19.8%
1,557,652
-13.0%
0.15%
-24.7%
Q3 2016$141,386,000
-5.4%
1,790,609
-1.1%
0.20%
-8.3%
Q2 2016$149,429,000
+3.9%
1,811,043
-8.8%
0.22%
+1.9%
Q1 2016$143,879,000
-17.5%
1,986,185
-2.0%
0.21%
-15.2%
Q4 2015$174,343,000
+2.0%
2,026,303
+9.0%
0.25%
-3.8%
Q3 2015$170,857,000
-9.8%
1,858,760
-3.5%
0.26%
-4.4%
Q2 2015$189,423,000
-2.3%
1,926,206
-2.1%
0.27%
-5.9%
Q1 2015$193,921,000
-9.0%
1,966,545
-14.5%
0.29%
-9.7%
Q4 2014$213,117,000
-4.1%
2,299,983
-2.6%
0.32%
-11.4%
Q3 2014$222,259,000
+1.5%
2,361,201
-2.3%
0.36%
-1.6%
Q2 2014$218,882,000
+1.6%
2,417,787
-4.6%
0.37%
-6.6%
Q1 2014$215,509,000
+18.5%
2,534,804
+12.1%
0.39%
+5.4%
Q4 2013$181,801,0002,261,7720.37%
Other shareholders
NOVARTIS A G shareholders Q1 2022
NameSharesValueWeighting ↓
Newman Dignan & Sheerar, Inc. 3,739$353,074,00056.77%
Susquehanna International Securities, Ltd. 118,837$11,222,0008.15%
MANAGED ASSET PORTFOLIOS, LLC 336,762$31,800,0005.59%
Martin Investment Management, LLC 169,019$15,960,0005.10%
SCHARF INVESTMENTS, LLC 1,197,539$113,083,0004.26%
GARLAND CAPITAL MANAGEMENT INC 50,705$4,788,0004.06%
Mawer Investment Management Ltd. 6,625,594$625,655,0003.69%
SPHERA FUNDS MANAGEMENT LTD. 429,000$40,510,0003.60%
First Fiduciary Investment Counsel, Inc. 196,693$18,574,0003.48%
PROFESSIONAL ADVISORY SERVICES INC 227,971$21,527,0003.46%
View complete list of NOVARTIS A G shareholders